Key Insights

Highlights

Success Rate

93% trial completion (above average)

Research Maturity

113 completed trials (48% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

3.4%

8 terminated out of 237 trials

Success Rate

93.4%

+6.9% vs benchmark

Late-Stage Pipeline

40%

95 trials in Phase 3/4

Results Transparency

4%

5 of 113 completed with results

Key Signals

5 with results93% success

Data Visualizations

Phase Distribution

227Total
Not Applicable (117)
Early P 1 (1)
P 1 (4)
P 2 (10)
P 3 (12)
P 4 (83)

Trial Status

Completed113
Recruiting46
Unknown42
Not Yet Recruiting20
Terminated8
Active Not Recruiting5

Trial Success Rate

93.4%

Benchmark: 86.5%

Based on 113 completed trials

Clinical Trials (237)

Showing 20 of 20 trials
NCT07639099Phase 4Not Yet Recruiting

Intranasal Esketamine-dexmedetomidine Combination and Postpartum Depression

NCT07377981Phase 4Not Yet RecruitingPrimary

Efficacy and Safety of Esketamine Combined With Dexmedetomidine in Non-Invasive ICU Patients With Hyperactive Delirium (ESSENTIAL Trial): Protocol of a Randomized Controlled Trial

NCT07610343Phase 4Not Yet Recruiting

Intranasal Dexmedetomidine-esketamine on Sleep and Cognition in Older Adults With Mild-to-moderate Cognitive Impairment

NCT07369128Phase 4Recruiting

Propofol-Only Versus Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging

NCT05863416Phase 4CompletedPrimary

Dexmedetomidine in Non-intubated VATS

NCT07611890Phase 4Recruiting

Dexmedetomidine vs Lignocaine for Reducing Intubation-Induced Hemodynamic Responses in Cardiac Surgery: A Randomized Controlled Trial

NCT07576543Phase 4Not Yet Recruiting

Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive Complications After Surgery

NCT07576517Phase 4Not Yet Recruiting

Dexmedetomidine-esketamine and tDCS for Prevention of Neurocognitive Complications After Surgery

NCT07580768Not ApplicableCompleted

Sedation With Dexmedetomidine or Midazolam in Combination With Propofol for Removal of Double-J Ureteral Stent

NCT07564037Not ApplicableCompletedPrimary

Nebulized Dexmedetomidine, Ketamine, or Midazolam in Children Undergoing Adenotonsillectomy

NCT07569614Not ApplicableCompleted

Comparative Effects of Remimazolam Tosylate and Dexmedetomidine on Postoperative Delirium in Elderly Patients Undergoing Thoracoscopic Surgery.

NCT07567495Phase 4Not Yet Recruiting

Adding Dexmedetomidine or Clonidine to Spinal Anesthesia for Cesarean Delivery

NCT07556133Not ApplicableRecruiting

Dexmedetomidine and Propofol for Sedation in Cataract Surgery.

NCT03624595Not ApplicableCompleted

Low-dose Dexmedetomidine and Postoperative Delirium After Cardiac Surgery

NCT07549282Phase 4Not Yet Recruiting

Use Dexmedetomidine To Protect Myocardial Injury Evaluation

NCT07162649Not ApplicableWithdrawnPrimary

Dexmedetomidine Nasal Spray for the Treatment of Panic Attacks in Adults

NCT07525999Phase 4Not Yet Recruiting

Dexmedetomidine-esketamine Combination and Chronic Postsurgical Pain After Spinal Surgery

NCT07523321Phase 4Not Yet Recruiting

Dexmedetomidine-esketamine Combination and Moderate-to-severe Pain After Spinal Surgery

NCT07308756Phase 4Recruiting

Impact of Perioperative Dexmedetomidine and Esketamine on Postoperative Quality of Recovery

NCT07523438Not ApplicableRecruitingPrimary

Effect of Intranasal Dexmedetomidine on the Incidence of Emergence Agitation in Children Undergoing Strabismus Surgery

Scroll to load more

Research Network

Activity Timeline